Healthcare Professionals
Please log in for special information and services
New here?
sign up for personal account

Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

Neurology & Metabolic Disorders

Adasuve®

Adasuve® is indicated for the rapid control of mild-to-moderate agitation (increased, unproductive physical activity coupled with internal tension) in adult patients with schizophrenia or biopolar disorder. Patients should receive regular treatment immediately after control of acute agitation symptoms. 

Drug Facts
Active Ingredient
Loxapine
HematoOncology

BESREMi®

BESREMi® is indicated as monotherapy in adults for the treatment of Polycythaemia Vera without symptomatic splenomegaly.

Drug Facts
Active Ingredient
Ropeginterferon alfa-2b
HematoOncology

Busilvex®

Busilvex® is a concentrate used to conditioning treatment prior to stem cell transplantation.

Drug Facts
Active Ingredient
Busulfan
HematoOncology

Canemes®

Canemes® prevents nausea and vomiting in patients undergoing chemotherapy for malignant tumours and is used if other drugs do not have the desired effect.

Drug Facts
Active Ingredient
Neurology & Metabolic Disorders

Dystardis®

Dystardis® is indicated for the treatment of moderate to severe late dyskinesia. Late dyskinesia is a disorder characterized by uncontrollable movements such as cramping in the stomach Face, making faces, or abnormal tongue movements.

Drug Facts
Active Ingredient
Tetrabenazine
Neurology & Metabolic Disorders

Feraccru®

Feraccru® is indicated for adults for the treatment of iron deficiency.

Drug Facts
Active Ingredient
Ferric-maltol
Neurology & Metabolic Disorders

Ospolot®

Ospolot® is an antiepileptic drug and is used to treat Rolandic epilepsy.

Drug Facts
Active Ingredient
Sultiame
Cardiology & Pulmonology

Remodulin®

Remodulin® is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with medium to severe symptoms.

Drug Facts
Active Ingredient
Treprostinil
Neurology & Metabolic Disorders

Tetmodis®

Tetmodis® is used as symptomatic therapy in the treatment of hyperkinetic motor disorders in Huntington’s disease. Tetrabenazine is also used in etiologies such as tardive dyskinesia, tics and dystonia.

Drug Facts
Active Ingredient
Tetrabenazine
HematoOncology

Thromboreductin®

Thromboreductin® is indicated for the reduction of elevated platelet counts and associated clinical symptoms in at high risk essential thrombocythemia patients

Drug Facts
Active Ingredient
Anagrelide
Neurology & Metabolic Disorders

Wakix®

Wakix® is indicated in adults for the treatment of narcolepsy with or without cataplexy.

Drug Facts
Active Ingredient
Pitolisant